Clinical Trial Update: Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR Inhibitors

View source ↗

Summary

This clinical trial update reports termination of studies evaluating EGFR inhibitors across multiple cancers, including anal, colon/rectal cancers and head and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• Colon Cancer
• Head and Neck Cancer
• Rectal Cancer

Snippet

Sponsor: Stanford University | Conditions: Anal, Colon, and Rectal Cancers, Head and Neck Cancer | Status: TERMINATED